Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The late Samsung Group chairman’s widow sells 15 million Samsung shares to pay off inheritance tax

The late Samsung Group chairman’s widow sells 15 million Samsung shares to pay off inheritance tax

格隆汇格隆汇2026/04/09 01:20
Show original
Glonghui, April 9th|Hong Ra-hee, widow of the late Samsung Group Chairman Lee Kun-hee, sold 15 million Samsung Electronics shares via block trade. The transaction was priced at 205,237 Korean won per share, with a total transaction amount of nearly 3.1 trillion Korean won (about $2.1 billion). After this reduction, Hong Ra-hee's stake in Samsung Electronics decreased from 1.49% to 1.24%. This cash-out marks the official conclusion of the Samsung family's five-year inheritance tax settlement plan, with the total inheritance tax left by Lee Kun-hee reaching approximately 12 trillion Korean won. Since April 2021, Hong Ra-hee and her children Lee Jae-yong, Lee Boo-jin, and Lee Seo-hyun have fulfilled their tax obligations in six installments through the sale of group subsidiaries' equity and multiple rounds of share pledge loans. With the final payment settled, the core shareholding reduction pressure that has troubled the Samsung family for many years is expected to be alleviated.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Goldman Sachs comments on AMD (AMD.US) Q3 performance: Data center CPU and GPU show strong performance, growth visibility for 2027 is clear

Goldman Sachs released a research report maintaining a "Buy" rating on AMD (AMD.US) with a 12-month target price of $675.

智通财经•2026/11/04 03:53

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51